AAAAAA
Results:
1-13
|
Results: 13
Authors:
Tatarczynska, E
Klodzinska, A
Kroczka, B
Chojnacka-Wojcik, E
Pilc, A
Citation: E. Tatarczynska et al., The antianxiety-like effects of antagonists of group I and agonists of group II and III metabotropic glutamate receptors after intrahippocampal administration, PSYCHOPHAR, 158(1), 2001, pp. 94-99
Authors:
Kroczka, B
Branski, P
Palucha, A
Pilc, A
Nowak, G
Citation: B. Kroczka et al., Antidepressant-like properties of zinc in rodent forced swim test, BRAIN RES B, 55(2), 2001, pp. 297-300
Authors:
Ossowska, K
Konieczny, J
Wolfarth, S
Wieronska, J
Pilc, A
Citation: K. Ossowska et al., Blockade of the metabotropic glutamate receptor subtype 5 (mGluR5) produces antiparkinsonian-like effects in rats, NEUROPHARM, 41(4), 2001, pp. 413-420
Authors:
Tatarczynska, E
Klodzinska, A
Chojnacka-Wojcik, E
Palucha, A
Gasparini, F
Kuhn, R
Pilc, A
Citation: E. Tatarczynska et al., Potential anxiolytic- and antidepressant-like effects of MPEP, a potent, selective and systemically active mGlu5 receptor antagonist, BR J PHARM, 132(7), 2001, pp. 1423-1430
Authors:
Lorenc-Koci, E
Wardas, J
Wolfarth, S
Pilc, A
Citation: E. Lorenc-koci et al., (S)-4C3HPG, a mixed group I mGlu receptor antagonist and a group II agonist, administered intrastriatally, counteracts parkinsonian-like muscle rigidity in rats, BRAIN RES, 903(1-2), 2001, pp. 177-184
Authors:
Pilc, A
Chojnacka-Wojcik, E
Tatarczynska, E
Borycz, J
Kroczka, B
Citation: A. Pilc et al., Stimulation of group II metabotropic glutamate receptors or inhibition of group I ones exerts anxiolytic-like effects in rats, AMINO ACIDS, 19(1), 2000, pp. 81-86
Authors:
Ossowska, K
Pietraszek, M
Wardas, J
Nowak, G
Zajaczkowski, W
Wolfarth, S
Pilc, A
Citation: K. Ossowska et al., The role of glutamate receptors in antipsychotic drug action, AMINO ACIDS, 19(1), 2000, pp. 87-94
Authors:
Wolfarth, S
Konieczny, J
Lorenc-Koci, E
Ossowska, K
Pilc, A
Citation: S. Wolfarth et al., The role of metabotropic glutamate receptor (mGluR) ligands in parkinsonian muscle rigidity, AMINO ACIDS, 19(1), 2000, pp. 95-101
Authors:
Frankiewicz, T
Pilc, A
Parsons, CG
Citation: T. Frankiewicz et al., Differential effects of NMDA-receptor antagonists on long-term potentiation and hypoxic/hypoglycaemic excitotoxicity in hippocampal slices, NEUROPHARM, 39(4), 2000, pp. 631-642
Authors:
Klodzinska, A
Bijak, M
Chojnacka-Wojcik, E
Kroczka, B
Swiader, M
Czuczwar, SJ
Pilc, A
Citation: A. Klodzinska et al., Roles of group II metabotropic glutamate receptors in modulation of seizure activity, N-S ARCH PH, 361(3), 2000, pp. 283-288
Authors:
Popik, P
Kozela, E
Pilc, A
Citation: P. Popik et al., Selective agonist of group II glutamate metabotropic receptors, LY354740, inhibits tolerance to analgesic effects of morphine in mice, BR J PHARM, 130(6), 2000, pp. 1425-1431
Authors:
Pilc, A
Branski, P
Palucha, A
Aronowski, J
Citation: A. Pilc et al., The effect of prolonged imipramine and electroconvulsive shock treatment on calcium/calmodulin-dependent protein kinase II in the hippocampus of rat brain, NEUROPHARM, 38(4), 1999, pp. 597-603
Authors:
Klodzinska, A
Chojnacka-Wojcik, E
Palucha, A
Branski, P
Popik, P
Pilc, A
Citation: A. Klodzinska et al., Potential anti-anxiety, anti-addictive effects of LY 354740, a selective group II glutamate metabotropic receptors agonist in animal models, NEUROPHARM, 38(12), 1999, pp. 1831-1839
Risultati:
1-13
|